US Stock MarketDetailed Quotes

ANI Pharmaceuticals (ANIP)

Watchlist
  • 85.290
  • +0.260+0.31%
Close Jan 15 16:00 ET
  • 85.290
  • 0.0000.00%
Post 16:10 ET
1.92BMarket Cap53.31P/E (TTM)

ANI Pharmaceuticals (ANIP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
53.58%227.81M
53.12%211.37M
43.43%197.12M
26.20%614.38M
44.75%190.57M
12.52%148.33M
18.44%138.04M
28.70%137.43M
53.87%486.82M
39.71%131.65M
Operating revenue
53.58%227.81M
53.12%211.37M
43.43%197.12M
26.20%614.38M
44.75%190.57M
12.52%148.33M
18.44%138.04M
28.70%137.43M
53.87%486.82M
39.71%131.65M
Cost of revenue
48.06%93.39M
29.32%74.62M
48.58%73.04M
37.85%250.21M
50.28%80.28M
31.13%63.08M
36.45%57.7M
30.36%49.16M
30.79%181.51M
47.06%53.42M
Gross profit
57.67%134.42M
70.22%136.76M
40.57%124.09M
19.28%364.17M
40.98%110.29M
1.83%85.26M
8.19%80.34M
27.79%88.27M
71.90%305.3M
35.11%78.23M
Operating expense
6.33%111.59M
62.52%121.59M
50.21%109.98M
41.51%361.95M
56.73%108.97M
53.58%104.95M
23.00%74.81M
28.25%73.22M
25.79%255.77M
31.44%69.52M
Selling and administrative expenses
-3.06%76.66M
54.81%81.77M
59.36%76.53M
54.39%249.64M
56.81%69.72M
88.24%79.08M
36.28%52.82M
31.68%48.02M
30.35%161.7M
33.97%44.46M
Research and development costs
21.48%12.3M
126.63%16.54M
0.50%10.56M
30.03%44.58M
68.70%16.65M
-8.93%10.13M
-1.06%7.3M
77.43%10.51M
53.62%34.29M
88.95%9.87M
Depreciation amortization depletion
43.71%22.63M
58.41%23.28M
55.87%22.89M
13.28%67.73M
48.74%22.6M
3.56%15.75M
0.05%14.7M
-0.10%14.69M
4.95%59.79M
4.90%15.19M
-Depreciation and amortization
43.71%22.63M
58.41%23.28M
55.87%22.89M
13.28%67.73M
48.74%22.6M
3.56%15.75M
0.05%14.7M
-0.10%14.69M
4.95%59.79M
4.90%15.19M
Operating profit
215.93%22.83M
174.40%15.17M
-6.33%14.1M
-95.52%2.22M
-84.74%1.33M
-227.94%-19.69M
-58.87%5.53M
25.60%15.06M
292.47%49.53M
73.80%8.71M
Net non-operating interest income expense
-102.79%-4.73M
-16.80%-5.44M
-19.22%-5.48M
34.66%-17.6M
-4.68%-6.02M
63.57%-2.33M
34.42%-4.66M
40.23%-4.6M
3.96%-26.94M
23.45%-5.75M
Non-operating interest expense
102.79%4.73M
16.80%5.44M
19.22%5.48M
-34.66%17.6M
4.68%6.02M
-63.57%2.33M
-34.42%4.66M
-40.23%4.6M
-3.96%26.94M
-23.45%5.75M
Other net income (expense)
265.68%15.7M
125.13%794K
-23.60%11.37M
-151.31%-6.83M
-349.75%-9.08M
-476.51%-9.47M
-189.82%-3.16M
800.24%14.88M
69.40%-2.72M
37.60%-2.02M
Gain on sale of security
131.73%3.14M
112.24%332K
-109.54%-921K
--6.31M
---1.99M
--1.36M
---2.71M
--9.66M
----
----
Special income (charges)
261.68%13.41M
-255.71%-1.28M
130.02%12.09M
-255.82%-9.1M
-187.51%-5.71M
-424.58%-8.29M
65.38%-359K
351.41%5.26M
73.21%-2.56M
37.81%-1.99M
-Less:Restructuring and merger&acquisition
-1,853.94%-14.47M
255.71%1.28M
-13,535.56%-12.09M
-124.20%-619K
-195.37%-1.89M
132.29%825K
-65.38%359K
-95.70%90K
-72.89%2.56M
-37.81%1.99M
-Less:Impairment of capital assets
--767K
----
----
--7.6M
--7.6M
--0
----
----
--0
----
-Less:Other special charges
----
----
----
--7.47M
--0
--7.47M
----
----
----
----
-Gain on sale of property,plant,equipment
---295K
--0
--0
--5.35M
--0
--0
--0
--5.35M
--0
--0
Other non- operating income (expenses)
66.35%-853K
2,076.14%1.74M
718.75%198K
-2,436.48%-4.03M
-4,075.76%-1.38M
-6,400.00%-2.54M
-66.04%-88K
5.88%-32K
-123.73%-159K
21.43%-33K
Income before tax
207.31%33.8M
560.21%10.53M
-21.11%19.99M
-211.78%-22.21M
-1,553.22%-13.76M
-373.63%-31.5M
-143.57%-2.29M
1,070.21%25.34M
131.71%19.87M
116.53%947K
Income tax
197.97%7.18M
1.98M
-39.59%4.31M
-437.60%-3.69M
-1,575.96%-3.49M
-566.71%-7.33M
0
881.82%7.13M
107.40%1.09M
85.99%-208K
Net income
210.14%26.62M
473.81%8.55M
-13.87%15.68M
-198.63%-18.52M
-989.70%-10.28M
-343.12%-24.17M
-136.62%-2.29M
1,165.25%18.21M
139.21%18.78M
127.22%1.16M
Net income continuous Operations
210.14%26.62M
473.81%8.55M
-13.87%15.68M
-198.63%-18.52M
-989.70%-10.28M
-343.12%-24.17M
-136.62%-2.29M
1,165.25%18.21M
139.21%18.78M
127.22%1.16M
Minority interest income
Net income attributable to the parent company
210.14%26.62M
473.81%8.55M
-13.87%15.68M
-198.63%-18.52M
-989.70%-10.28M
-343.12%-24.17M
-136.62%-2.29M
1,165.25%18.21M
139.21%18.78M
127.22%1.16M
Preferred stock dividends
-15.27%344K
0.00%407K
0.00%406K
0.00%1.63M
0.00%406K
0.00%406K
0.00%407K
0.00%406K
0.00%1.63M
-0.25%406K
Other preferred stock dividends
Net income attributable to common stockholders
206.92%26.27M
402.23%8.14M
-14.19%15.28M
-217.45%-20.15M
-1,526.17%-10.68M
-357.73%-24.57M
-146.15%-2.69M
1,623.23%17.8M
134.64%17.15M
116.11%749K
Basic earnings per share
193.70%1.19
364.29%0.37
-16.67%0.7
-220.93%-1.04
-2,850.00%-0.55
-376.09%-1.27
-146.67%-0.14
1,300.00%0.84
128.20%0.86
107.14%0.02
Diluted earnings per share
188.98%1.13
357.14%0.36
-15.85%0.69
-222.35%-1.04
-2,850.00%-0.55
-382.22%-1.27
-148.28%-0.14
1,266.67%0.82
127.87%0.85
107.14%0.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 53.58%227.81M53.12%211.37M43.43%197.12M26.20%614.38M44.75%190.57M12.52%148.33M18.44%138.04M28.70%137.43M53.87%486.82M39.71%131.65M
Operating revenue 53.58%227.81M53.12%211.37M43.43%197.12M26.20%614.38M44.75%190.57M12.52%148.33M18.44%138.04M28.70%137.43M53.87%486.82M39.71%131.65M
Cost of revenue 48.06%93.39M29.32%74.62M48.58%73.04M37.85%250.21M50.28%80.28M31.13%63.08M36.45%57.7M30.36%49.16M30.79%181.51M47.06%53.42M
Gross profit 57.67%134.42M70.22%136.76M40.57%124.09M19.28%364.17M40.98%110.29M1.83%85.26M8.19%80.34M27.79%88.27M71.90%305.3M35.11%78.23M
Operating expense 6.33%111.59M62.52%121.59M50.21%109.98M41.51%361.95M56.73%108.97M53.58%104.95M23.00%74.81M28.25%73.22M25.79%255.77M31.44%69.52M
Selling and administrative expenses -3.06%76.66M54.81%81.77M59.36%76.53M54.39%249.64M56.81%69.72M88.24%79.08M36.28%52.82M31.68%48.02M30.35%161.7M33.97%44.46M
Research and development costs 21.48%12.3M126.63%16.54M0.50%10.56M30.03%44.58M68.70%16.65M-8.93%10.13M-1.06%7.3M77.43%10.51M53.62%34.29M88.95%9.87M
Depreciation amortization depletion 43.71%22.63M58.41%23.28M55.87%22.89M13.28%67.73M48.74%22.6M3.56%15.75M0.05%14.7M-0.10%14.69M4.95%59.79M4.90%15.19M
-Depreciation and amortization 43.71%22.63M58.41%23.28M55.87%22.89M13.28%67.73M48.74%22.6M3.56%15.75M0.05%14.7M-0.10%14.69M4.95%59.79M4.90%15.19M
Operating profit 215.93%22.83M174.40%15.17M-6.33%14.1M-95.52%2.22M-84.74%1.33M-227.94%-19.69M-58.87%5.53M25.60%15.06M292.47%49.53M73.80%8.71M
Net non-operating interest income expense -102.79%-4.73M-16.80%-5.44M-19.22%-5.48M34.66%-17.6M-4.68%-6.02M63.57%-2.33M34.42%-4.66M40.23%-4.6M3.96%-26.94M23.45%-5.75M
Non-operating interest expense 102.79%4.73M16.80%5.44M19.22%5.48M-34.66%17.6M4.68%6.02M-63.57%2.33M-34.42%4.66M-40.23%4.6M-3.96%26.94M-23.45%5.75M
Other net income (expense) 265.68%15.7M125.13%794K-23.60%11.37M-151.31%-6.83M-349.75%-9.08M-476.51%-9.47M-189.82%-3.16M800.24%14.88M69.40%-2.72M37.60%-2.02M
Gain on sale of security 131.73%3.14M112.24%332K-109.54%-921K--6.31M---1.99M--1.36M---2.71M--9.66M--------
Special income (charges) 261.68%13.41M-255.71%-1.28M130.02%12.09M-255.82%-9.1M-187.51%-5.71M-424.58%-8.29M65.38%-359K351.41%5.26M73.21%-2.56M37.81%-1.99M
-Less:Restructuring and merger&acquisition -1,853.94%-14.47M255.71%1.28M-13,535.56%-12.09M-124.20%-619K-195.37%-1.89M132.29%825K-65.38%359K-95.70%90K-72.89%2.56M-37.81%1.99M
-Less:Impairment of capital assets --767K----------7.6M--7.6M--0----------0----
-Less:Other special charges --------------7.47M--0--7.47M----------------
-Gain on sale of property,plant,equipment ---295K--0--0--5.35M--0--0--0--5.35M--0--0
Other non- operating income (expenses) 66.35%-853K2,076.14%1.74M718.75%198K-2,436.48%-4.03M-4,075.76%-1.38M-6,400.00%-2.54M-66.04%-88K5.88%-32K-123.73%-159K21.43%-33K
Income before tax 207.31%33.8M560.21%10.53M-21.11%19.99M-211.78%-22.21M-1,553.22%-13.76M-373.63%-31.5M-143.57%-2.29M1,070.21%25.34M131.71%19.87M116.53%947K
Income tax 197.97%7.18M1.98M-39.59%4.31M-437.60%-3.69M-1,575.96%-3.49M-566.71%-7.33M0881.82%7.13M107.40%1.09M85.99%-208K
Net income 210.14%26.62M473.81%8.55M-13.87%15.68M-198.63%-18.52M-989.70%-10.28M-343.12%-24.17M-136.62%-2.29M1,165.25%18.21M139.21%18.78M127.22%1.16M
Net income continuous Operations 210.14%26.62M473.81%8.55M-13.87%15.68M-198.63%-18.52M-989.70%-10.28M-343.12%-24.17M-136.62%-2.29M1,165.25%18.21M139.21%18.78M127.22%1.16M
Minority interest income
Net income attributable to the parent company 210.14%26.62M473.81%8.55M-13.87%15.68M-198.63%-18.52M-989.70%-10.28M-343.12%-24.17M-136.62%-2.29M1,165.25%18.21M139.21%18.78M127.22%1.16M
Preferred stock dividends -15.27%344K0.00%407K0.00%406K0.00%1.63M0.00%406K0.00%406K0.00%407K0.00%406K0.00%1.63M-0.25%406K
Other preferred stock dividends
Net income attributable to common stockholders 206.92%26.27M402.23%8.14M-14.19%15.28M-217.45%-20.15M-1,526.17%-10.68M-357.73%-24.57M-146.15%-2.69M1,623.23%17.8M134.64%17.15M116.11%749K
Basic earnings per share 193.70%1.19364.29%0.37-16.67%0.7-220.93%-1.04-2,850.00%-0.55-376.09%-1.27-146.67%-0.141,300.00%0.84128.20%0.86107.14%0.02
Diluted earnings per share 188.98%1.13357.14%0.36-15.85%0.69-222.35%-1.04-2,850.00%-0.55-382.22%-1.27-148.28%-0.141,266.67%0.82127.87%0.85107.14%0.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More